NPS Pharma (NPSP) Misses Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts NPSP Hot Sheet
Price: $45.97 --0%
Financial Fact:
Total operating expenses: 52.67M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Financial Fact:
Total operating expenses: 52.67M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
NPS Pharma (NASDAQ: NPSP) reported Q4 EPS of ($0.02), $0.08 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $66.7 million versus the consensus estimate of $69.3 million.
For earnings history and earnings-related data on NPS Pharma (NPSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
- Cullen/Frost Bankers (CFR) Misses Q1 EPS by 3c
- FTI Consulting (FCN) Tops Q1 EPS by 40c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
